However, Rab27a and Rab27b have sometimes been reported to act as tumor suppressors, because they are downregulated in colorectal and prostate cancers and their lower levels of expression are correlated with worse outcomes (Dong et al., 2015; Worst et al., 2017). This evidence concerns the gene RAB27B and neoplasm.